|
gptkbp:instanceOf
|
Cannabis
psychoactive compound
|
|
gptkbp:abbreviation
|
gptkb:THC
|
|
gptkbp:actsOn
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:boilingPoint
|
157 °C
|
|
gptkbp:CASNumber
|
1972-08-3
|
|
gptkbp:category
|
controlled substance
recreational drug
metabolite
phytocannabinoid
plant metabolite
terpenophenolic compound
medical drug
neurotoxin (in high doses)
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:discoveredBy
|
gptkb:Raphael_Mechoulam
|
|
gptkbp:discoveredIn
|
1964
|
|
gptkbp:effect
|
euphoria
altered perception
increased appetite
psychoactive
|
|
gptkbp:eliminationHalfLife
|
1.3 days (frequent users)
5-13 days (infrequent users)
|
|
gptkbp:enemyOf
|
gptkb:rimonabant
|
|
gptkbp:foundIn
|
Cannabis
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tetrahydrocannabinol
|
|
gptkbp:IUPACName
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:meltingPoint
|
66 °C
|
|
gptkbp:metabolism
|
gptkb:11-hydroxy-THC
gptkb:THC-COOH
liver
|
|
gptkbp:molecularWeight
|
314.464 g/mol
|
|
gptkbp:notableIsomer
|
gptkb:Delta-10-THC
gptkb:Delta-8-THC
|
|
gptkbp:predecessor
|
gptkb:cannabigerolic_acid
gptkb:tetrahydrocannabinolic_acid
|
|
gptkbp:routeOfAdministration
|
oral
topical
inhalation
sublingual
|
|
gptkbp:sideEffect
|
anxiety
paranoia
increased heart rate
dry mouth
impaired memory
|
|
gptkbp:solubility
|
lipid-soluble
|
|
gptkbp:usedFor
|
medical marijuana
|
|
gptkbp:bfsParent
|
gptkb:Cannabis
|
|
gptkbp:bfsLayer
|
6
|